ALKALOID AMINOESTER DERIVATIVES AND MEDICINAL COMPOSITION THEREOF
申请人:Caligiuri Antonio
公开号:US20100173880A1
公开(公告)日:2010-07-08
Alkaloid aminoester compounds which act as muscarinic receptor antagonists are useful for the prevention and/or treatment of a broncho-obstructive or inflammatory diseases.
具有肌碱受体拮抗作用的生物碱氨酯化合物对于预防和/或治疗支气管阻塞性或炎症性疾病是有用的。
ALBUMIN-BINDING COMPOUNDS THAT PREVENT NONENZYMATIC GLYCATION AND THAT MAY BE USED FOR TREATMENT OF GLYCATION-RELATED PATHOLOGIES
申请人:EXOCELL, INC.
公开号:EP1242069A2
公开(公告)日:2002-09-25
US8455646B2
申请人:——
公开号:US8455646B2
公开(公告)日:2013-06-04
US8835682B2
申请人:——
公开号:US8835682B2
公开(公告)日:2014-09-16
[EN] ALBUMIN-BINDING COMPOUNDS THAT PREVENT NONENZYMATIC GLYCATION AND THAT MAY BE USED FOR TREATMENT OF GLYCATION-RELATED PATHOLOGIES<br/>[FR] COMPOSES LIANT L'ALBUMINE QUI EMPECHENT LA GLYCATION NON ENZYMATIQUE ET QUI PEUVENT ETRE UTILISES DANS LE TRAITEMENT DE PATHOLOGIES LIEES A LA GLYCATION
申请人:EXOCELL INC
公开号:WO2001003684A2
公开(公告)日:2001-01-18
The present invention is directed to compositions, comprising substituted 2(pheryl amino) pheryl acetic acid compounds, that inhibit the nonenzymatic glycation of albumin, as well as methods of using compounds that inhibit albumin glycation for the treatment of glycation-related pathologies including renol vascular dysfunction.